Noah Dobson, Ivan Demidov, Zachary Bolduc and David Reinbacher should all be in the starting line-up next October. Reinbacher may be less certain, but I like his chances.

There’s a new kid on the block in the fast-growing radiopharmaceuticals category, as Nucleus RadioPharma chalks up an oversubscribed Series A that raised $56 million that will b ...

Historical Perspective Published: May 1999 A unifying concept: the history of cell theory Paolo Mazzarello Nature Cell Biology 1, E13–E15 (1999) Cite this article ...

In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen looked through what worked in 2025, what didn’t and where we are opening 2026. View the presentation slides ...

A Venn diagram, created using TBtools software, was used to illustrate the number of DEGs at the intersection of CK20 vs. One20, CK20 vs. Two20, CK80 vs. One80, and CK80 vs. Two80 (Chen et al., 2020).